-
From the Editor-in-Chief
A New Treatment for Some Brain TumorsA recently approved therapy targets abnormal enzymes produced by gene defects.
by William G. Nelson, MD, PhD
-
Forward Look
Stem Cell Transplant Rates Decrease for LymphomaMore patients are receiving CAR T-cell therapy for large B-cell lymphoma.
by Leah Lawrence
-
Forward Look
Rethinking Cancer Drug DosesResearchers and patients push to move away from maximum tolerated dose in research.
by Natalie Slivinski
-
Reducing the Burden of RadiationShorter courses of more intense radiation therapy mean fewer visits and less cost for patients. Studies show abbreviated treatments are just as effective as longer courses.
by Stephen Ornes
-
Making Their MarkWith targeted therapy options available for a growing number of cancer types, biomarker testing is making a difference for more people with solid cancers.
by Kendall K. Morgan
-
Cancer Care for Older AdultsGeriatric assessments can help physicians and older patients choose effective treatments with fewer side effects.
by Eric Fitzsimmons
-
Q&A
Solving a Medical MysteryJournalist Lawrence Ingrassia traces the scientific history of a genetic disorder that predisposes families like his to cancer.
by Thomas Celona
-
Forward Look
Cognition and Prostate CancerAndrogen deprivation therapy, a common prostate cancer treatment, may increase cognitive difficulties.
by Joseph Jalkiewicz
-
Rethinking the Role of RadiationChest radiation may not be necessary for people with intermediate-risk breast cancer.
by Thomas Celona
-
De-escalating Treatment for DCISResearch finds certain people with low-risk DCIS may be able to forgo surgery or radiation.
by Thomas Celona
U.S. breast cancer deaths declined for women ages 20 to 49, which researchers credit to wider screening and better treatment.
by Kevin McLaughlin
Missed Activities Due to Cancer-related Fatigue and DepressionWomen were more likely than men to have fatigue or depression linked to cancer, and both effects were linked to people withdrawing from physical activities.
by Eric Fitzsimmons
Immunotherapy Improves Results in Head and Neck CancerCombining an immune checkpoint inhibitor with standard care extended event-free survival by nearly two years.
by Thomas Celona
Federal Support for Cancer Research Takes the Stage at AACR Annual MeetingScientists and former administrators gather for session focused on advocating for cancer research in uncertain times.
by Kevin McLaughlin
-
Inaugural AACR IO Conference Kicks Off With Celebration of Immune CheckpointsImmune checkpoint icons James Allison and Arlene Sharpe shared their journeys and a look ahead on the opening night of the inaugural AACR IO conference.
-
A New Resource Provides a Sanctuary for Black TNBC PatientsThe Black TNBC Sanctuary was created to help Black women with triple-negative breast cancer get answers about their diagnosis and care.
Dr. Humberto M. Guiot: Targeting Pancreatic Cancer in a Community-Based Clinical Trial
